Revvity Inc Quick Ratio (RVTY) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Revvity Inc  (NYSE: RVTY)

Revvity Inc's Quick Ratio

RVTY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.67 below Revvity Inc average.

Within Laboratory Analytical Instruments industry 15 other companies have achieved higher Quick Ratio than Revvity Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 2346, from total ranking in the first quarter 2026 at 2859.

Explain Quick Ratio?
How much Cash & cash equivalents RVTY´s has?
What are RVTY´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RVTY Quick Ratio (Jul 05 2026)
Q2		 (Apr 05 2026)
Q1		 (Dec 28 2025)
Q4		 (Sep 28 2025)
Q3		 (Jun 29 2025)
Q2
Y / Y Current Liabilities Change 125.68 % 91.09 % 103.83 % 77.74 % -51.67 %
Y / Y Cash & cash equivalent Change 3.13 % -24.38 % -20.93 % -24.26 % -49.25 %
Quick Ratio MRQ 0.67 0.69 0.69 0.76 1.48
RVTY's Total Ranking # 2346 # 2859 # 2580 # 1902 # 1761
Seq. Current Liabilities Change 22.4 % -6.96 % 8.87 % 82.01 % 3.65 %
Seq. Cash & cash equivalent Change 18.9 % -6.47 % -1.24 % -6.1 % -12.81 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 702
Overall Market # 2344


Quick Ratio Statistics
High Average Low
3.82 0.98 0.2
(Oct 01 2017)   (Jan 03 2021)




Financial Statements
Revvity Inc's Current Liabilities $ 1,516 Millions Visit RVTY's Balance sheet
Revvity Inc's Cash & cash equivalent $ 1,023 Millions Visit RVTY's Balance sheet
Source of RVTY's Sales Visit RVTY's Sales by Geography


Cumulative Revvity Inc's Quick Ratio

RVTY's Quick Ratio for the trailling 12 Months

RVTY Quick Ratio

 (Jul 05 2026)
12 Months		 (Apr 05 2026)
12 Months		 (Dec 28 2025)
12 Months		 (Sep 28 2025)
12 Months		 (Jun 29 2025)
12 Months
Y / Y Current Liabilities TTM Growth 99.5 % 32.11 % -5.63 % -39.03 % -55.66 %
Y / Y Cash & cash equivalent TTM Growth -17.43 % -32.48 % -34.12 % -34.84 % -32.32 %
Quick Ratio TTM 0.7 0.83 1.03 1.32 1.7
Total Ranking TTM # 1476 # 1453 # 890 # 724 # 872
Seq. Current Liabilities TTM Growth 18.91 % 15.24 % 21.22 % 20.1 % -21.25 %
Seq. Cash & cash equivalent TTM Growth 0.84 % -6.97 % -5.77 % -6.6 % -17.55 %

Quick ratio ranking by company, industry and sector >> Back to RVTY Financial Strength Comparisons >> Go to Compare RVTY Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2026 to $1,516.16 millions, cumulative Quick Ratio decreased to 0.7 above the RVTY average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Revvity Inc. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2212.

Explain Quick Ratio?
How much Cash & cash equivalents RVTY´s has?
What are RVTY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 900
Within the Market # 2346


trailing twelve months Quick Ratio Statistics
High Average Low
1.7 0.51 0.21
(Jun 29 2025)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Jul 05 2026, within Laboratory Analytical Instruments Industry Quick RatioJul 05 2026 MRQ Cash & cash equivalentJul 05 2026 MRQ Current Liabilities
Nautilus Biotechnology Inc   1.52 $ 13.166  Millions$ 8.639  Millions
Rapid Micro Biosystems Inc   1.13 $ 20.500  Millions$ 18.150  Millions
Bionano Genomics Inc   1.04 $ 10.420  Millions$ 10.039  Millions
Bio rad Laboratories Inc   0.92 $ 886.900  Millions$ 961.300  Millions
Precipio inc   0.83 $ 3.075  Millions$ 3.701  Millions
Lifeloc Technologies Inc   0.83 $ 0.908  Millions$ 1.099  Millions
Agilent Technologies inc   0.77 $ 1,758.000  Millions$ 2,289.000  Millions
Revvity Inc  0.67 $ 1,022.943  Millions$ 1,516.157  Millions
Harvard Bioscience Inc   0.26 $ 6.503  Millions$ 24.793  Millions
Waters Corporation  0.22 $ 539.000  Millions$ 2,399.000  Millions
Kewaunee Scientific Corporation  0.22 $ 10.261  Millions$ 47.235  Millions
Bruker Corporation  0.18 $ 217.200  Millions$ 1,204.700  Millions

Date modified: 2026-09-26T07:19:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.